Data management

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

15-Nov-2024 By Liza Laws

Genesis also announced a further investment from NVentures, NVIDIA’s venture capital arm.

US companies enhancing decentralized clinical trials

13-Nov-2024 By Larissa Warneck-Silvestrin

Traditional clinical trials usually rely on several physical trial sites to recruit and monitor patients.

The decentralized clinical trials market will grow to $25 billion by 2032

13-Nov-2024 By Clara Rodriguez Fernando

Driven by the effects of the COVID-19 pandemic, the market for decentralized clinical trials has seen a push that will lead it to more than triple in size within the next decade.

Transparency and remote options key in clinical trial engagement

13-Nov-2024 By Liza Laws

A recent Lindus Health survey emphasizes the importance of patient-centered designs in clinical trials, particularly highlighting how telehealth options could improve accessibility and convenience for participants.

Gifthealth and United Digestive partner for enhanced GI care access

12-Nov-2024 By Liza Laws

Gifthealth Partners with United Digestive to boost patient access and procedure prep.

Abbisko’s pimicotinib hits primary endpoint in phase 3 TGCT trial

12-Nov-2024 By Jonathan Smith

Abbisko’s small molecule drug pimicotinib has smashed the primary goal of a phase 3 trial for the treatment of tenosynovial giant cell tumor (TGCT), taking the asset a step further to the market in China and elsewhere.

Private equity firms GHO and Ampersand acquire Avid Bioservices for $1.1 billion

12-Nov-2024 By Clara Rodriguez Fernandez

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the acquisition of Avid Bioservices.

Palomar Health inspires youth with hands-on medical program

05-Nov-2024 By Liza Laws

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Novo Nordisk’s semaglutide shows additional cardiovascular benefits in overweight patients

05-Nov-2024 By Clara Rodriguez Fernandez

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and obese adults with heart disease.

Thermo Fisher integrates Labguru ELN for streamlined lab management

04-Nov-2024 By Liza Laws

Thermo Fisher Scientific has joined forces with Labguru to integrate Labguru’s Electronic Lab Notebook (ELN) into Thermo Fisher’s Laboratory Information Management System (LIMS) and lab operations software.

Abzena’s advanced drug development showcased at CPHI Milan

01-Nov-2024 By Liza Laws

At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO platform and ThioBridge linker technology.

GSK beefs up US manufacturing site with $800 million investment

29-Oct-2024 By Jonathan Smith

The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, to double its size and capacity.

Rentschler Biopharma expands CDMO facilities in Germany

29-Oct-2024 By Clara Rodriguez Fernandez

The expansion will involve the construction of a new buffer media facility and represents the largest investment from Rentschler at its Germany headquarters.

CRO NovAliX teams with Bruker to advance drug development

29-Oct-2024 By Liza Laws

In a move set to transform drug discovery, CRO NovAliX has partnered with Bruker, a leader in scientific instruments, through a strategic investment aimed at enhancing drug development success rates.

Radiopharmaceutical CDMO launched by NorthStar Medical Radioisotopes

24-Oct-2024 By Jonathan Smith

The US manufacturer NorthStar Medical Radioisotopes has unveiled a Contract Development & Manufacturing (CDMO) facility dedicated to the production and development of medical radioisotopes.

NICE rejects Donanemab for NHS use despite MHRA approval

23-Oct-2024 By Liza Laws

Donanemab marks a significant advancement in Alzheimer’s treatment, but NHS patients face a setback with NICE's rejection of its cost-effectiveness.

Sanofi abandons phase 2 trial of Denali’s multiple sclerosis candidate

15-Oct-2024 By Jonathan Smith

The big pharma company Sanofi has discontinued a phase 2 trial of U.S. partner Denali Therapeutics’ oditrasertib for the treatment of multiple sclerosis after the drug failed to perform.

How a CDMO is staying on top of API and drug product manufacturing trends

15-Oct-2024 By Larissa Worneck-Silvestrin

As active pharmaceutical ingredients (APIs) and medicines become more complex and the demand for efficiency rises, drug developers and manufacturers must adapt their strategies to keep pace with the evolving landscape.

Jane Koo on leading regulatory affairs at CTMC: A journey from mAbs to cellular therapies

11-Oct-2024 By Liza Laws

Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization of innovative cellular therapies.

Evaxion’s AI-immunology platform shines in multiple clinical trials

10-Oct-2024 By Larissa Warneck-Silvestrin

Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer vaccine targets.

Preparing for the US Biosecure Act - what does it mean for the pharma industry?

08-Oct-2024 By Helen Albert

The US Biosecure Act was passed by the House of Representatives in September and seems likely to become law.

Drug discovery and bringing new medicine to market - the future of AI in pharma

08-Oct-2024 By Liza Laws

Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a value of $22.6 billion dollars by next year (2025).

From CDMOs to artificial intelligence - what's the latest in the world of outsourcing?

04-Oct-2024 By Liza Laws

Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of pharmaceutical outsourcing.

How specialized vendors improve patient recruitment success

04-Oct-2024 By Liza Laws

Patient recruitment is a critical and often challenging aspect of clinical trials, particularly for biopharmaceutical companies seeking to accelerate drug development.

CPHI Milan 2024: Enzene targets cost savings and efficiency

02-Oct-2024 By Liza Laws

Enzene's monoclonal antibody production costs to dip below $40 per gram by 2025.

Authenticx CPO Eric Prugh on the impact of AI technology in pharmacovigilance

01-Oct-2024 By Clara Rodriguez Ferndandez

Artificial intelligence has emerged as a potential solution to inconsistent reporting of adverse events, which to this day remains one of the main challenges in the field of pharmacovigilance.

Insilico Medicine claims phase 2 win for AI-designed drug

19-Sep-2024 By By Helen Albert

The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met its primary endpoint.

Boehringer Ingelheim score with phase 3 idiopathic pulmonary fibrosis win

17-Sep-2024 By Helen Albert

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

F2G raises $100 million to combat innovation 'paucity' in antifungals

17-Sep-2024 By Jonathan Smith

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal infections in 2026.

uMotif expands site and patient platform with ClinOne acquisition

17-Sep-2024 By Liza Laws

uMotif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its platform with the acquisition of ClinOne, a provider of site platform solutions.

Vaxess' Rachel Sha - 'own the seat at the table that you have and have confidence'

16-Sep-2024 By Liza Laws

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have confidence and answer hard questions.

How early utilisation of AI can de-risk and accelerate clinical development

12-Sep-2024 By Liza Laws

Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) potential to transform drug development.

The intersection of ethics and AI in healthtech marketing: Insights from ObvioHealth

12-Sep-2024 By Liza Laws

In the crowded landscape of health tech, ethical marketing has emerged as a crucial differentiator for companies striving to stand out.

Phastar's RBQM app enhances clinical trial data monitoring

11-Sep-2024 By Liza Laws

Phastar have implemented an RBQM app within their Clinical Intelligence Data Visualisation Platform, enabling a comprehensive overview of the entire trial across all sites which can be shown in various visualisation graphs, tailored by client.

CluePoints sponsors RBQMLive 2024, focusing on risk-based quality management

11-Sep-2024 By Liza Laws

CluePoints, the leading provider of risk-based quality management (RBQM) and data quality oversight software, has announced the full agenda and speaker line-up for the highly anticipated RBQMLive 2024.

Medidata and EORTC strengthen collaboration for oncology data management

11-Sep-2024 By Liza Laws

The European Organisation for Research and Treatment of Cancer (EORTC) has renewed and extended its partnership with Medidata, a provider of clinical trial solutions for the life sciences industry.

Slope offering further deep, specialized expertise thanks to new services

11-Sep-2024 By Liza Laws

Slope, a global provider of biospecimen lifecycle software, data, and services for clinical trials, has announced the launch of a new suite of premium services designed to optimize biospecimen operations and data management.

EnvisionOne Insights: Transforming data management in life sciences

11-Sep-2024 By Liza Laws

Envision Pharma Group, a global leader in technology solutions for the life sciences industry, has unveiled its latest innovation, EnvisionOne Insights.

Women in Science - Beate Mueller on the privilege of bringing solutions closer to patients

10-Sep-2024 By Liza Laws

Beate Mueller-Tiemann is chief technology officer at Cytiva.

Pharma companies must prioritize patient reach, report says

10-Sep-2024 By Liza Laws

Pharmaceutical companies are under increasing pressure to ensure that essential healthcare products are accessible to all, regardless of socioeconomic status or location.

Creyon Bio secures second patent for AI-powered oligonucleotide engineering

10-Sep-2024 By Liza Laws

Creyon Bio Inc., a clinical-stage biotechnology company specializing in AI and machine learning-enabled oligonucleotide-based medicines (OBMs), recently announced the issuance of its second US patent.

AI-driven insights: SOMS boosts clinical trial success

05-Sep-2024 By Liza Laws

In an in-depth conversation, OSP senior editor, Liza Laws, interviews Adrian Kizewski, associate director at IQVIA, to uncover the transformative impact of the Sub-population Optimization & Modeling Solution (SOMS) on clinical trials.

Seqster and PatientsLikeMe partner to enhance patient data engagement

05-Sep-2024 By Liza Laws

Seqster and PatientsLikeMe have announced a strategic partnership to integrate real-time electronic health record (EHR) data with patient engagement tools, aiming to significantly improve clinical research and patient outcomes.

Metagenomics revolution: Empress Therapeutics on drug discovery breakthroughs

03-Sep-2024 By Liza Laws

Dr Dawn Thompson has over 20 years of experience in building technology platforms that leverage genomics at scale to produce novel products.

New XpressGT kit speeds up diagnosis of diabetes, endometriosis and liver disease

23-Aug-2024 By Liza Laws

DirectSens, an Austrian biosensor developer, has launched its latest innovation, the XpressGT RUO kit, designed for the detection of conditions related to insulin resistance, including gestational diabetes (GDM), endometriosis, and liver disease.

Intelliguard and Cencora partner to streamline RFID medication management

14-Aug-2024 By Liza Laws

Intelliguard, a leader in medication management and data-intelligence solutions, has announced a partnership with Cencora, a global pharmaceutical solutions provider.

Boosting pharma security: Systech's track and trace tech

14-Aug-2024 By Liza Laws

In the fight against counterfeit pharmaceuticals, Systech stands at the forefront with its advanced track and trace technology.

How nuVizz transforms pharma supply chains: Insights from its CEO, Guru Rao

14-Aug-2024 By Liza Laws

In the ever-evolving world of pharmaceutical logistics, nuVizz has emerged as a key player, delivering innovative solutions that streamline the delivery management process.

Certa’s CEO Jag Lamba on enhancing pharma supply chain traceability and compliance

14-Aug-2024 By Liza Laws

In an increasingly complex regulatory landscape, pharmaceutical companies face significant challenges in maintaining transparency and accountability across their global supply chains.

SSNL - track and trace

TraceLink and Tecsys partnership: healthcare supply chain with integrated digital solutions

14-Aug-2024 By Liza Laws

In a strategic move aimed at transforming healthcare supply chains, TraceLink, a leading provider of digital supply chain solutions, has partnered with Tecsys, an industry leader in inventory and warehouse management systems.